English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Talk

Involvement of cerebellum in the dopaminergic treatment of Parkinson’s disease: A resting-state fMRI study

MPS-Authors
/persons/resource/persons22883

Holiga,  Štefan
Methods and Development Unit Nuclear Magnetic Resonance, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

Mueller,  Karsten
Methods and Development Unit Nuclear Magnetic Resonance, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

/persons/resource/persons19864

Moeller,  Harald E.
Methods and Development Unit Nuclear Magnetic Resonance, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

/persons/resource/persons19821

Lohmann,  Gabriele
Department Neurophysics, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

/persons/resource/persons19981

Schroeter,  Matthias
Department Neurology, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Holiga, Š., Mueller, K., Moeller, H. E., Lohmann, G., Sieger, T., Vymazal, J., et al. (2013). Involvement of cerebellum in the dopaminergic treatment of Parkinson’s disease: A resting-state fMRI study. Talk presented at 21st Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM). Salt Lake City, UT, USA. 2013-04-20 - 2013-04-26.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-B6AB-4
Abstract
There is no abstract available